TriMas Soars: Q3 Net Income Jumps 267% on Strong Aerospace Demand

TL;DR

**TRS is flying high with massive Q3 profit growth and a smart aerospace acquisition, making it a strong buy.**

AI Summary

TRIMAS CORP (TRS) reported a robust financial performance for the three and nine months ended September 30, 2025. Net sales increased significantly by 17.4% to $269.26 million for the three months ended September 30, 2025, up from $229.36 million in the prior year period. For the nine months, net sales grew by 12.7% to $785.69 million, compared to $696.96 million in 2024. Net income saw a substantial rise, reaching $9.30 million for the quarter, a 267.6% increase from $2.53 million in the same quarter last year. Year-to-date net income more than doubled to $38.44 million from $18.61 million. A key business change was the acquisition of GMT Gummi-Metall-Technik GmbH's aerospace business for $37.7 million on February 17, 2025, contributing to the strong performance in the Aerospace & Defense segment, which saw sales jump 45.8% to $103.24 million for the quarter. Risks include increased asbestos-related costs, which rose to $8.03 million for the quarter from $5.51 million in 2024, and ongoing realignment costs of $4.9 million year-to-date. The strategic outlook appears positive, driven by strong demand in aerospace and consumer products, and effective management of operational costs despite inflationary pressures.

Why It Matters

This strong performance, particularly the significant net income growth and strategic acquisition, signals robust operational health for TriMas, making it an attractive prospect for investors. The substantial increase in Aerospace & Defense segment sales, driven by the GMT acquisition, positions TriMas competitively against peers by expanding its market share and product offerings in a high-growth sector. For employees, this growth could mean increased job security and potential for expansion. Customers benefit from an enhanced product portfolio and potentially more innovative solutions. The broader market sees a company successfully navigating economic headwinds, demonstrating resilience and strategic foresight in a competitive industrial landscape.

Risk Assessment

Risk Level: medium — The risk level is medium due to rising asbestos-related costs, which increased to $8.03 million for the three months ended September 30, 2025, from $5.51 million in the prior year. Additionally, the company incurred $4.9 million in realignment costs during the nine months ended September 30, 2025, indicating ongoing operational adjustments that could impact future profitability, despite strong overall financial performance.

Analyst Insight

Investors should consider increasing their position in TRS, given the significant net income growth of 267.6% and the strategic acquisition in the high-growth aerospace sector. Monitor future filings for continued integration success of the GMT acquisition and any further increases in asbestos-related liabilities.

Financial Highlights

debt To Equity

0.56

revenue

$269.26M

operating Margin

6.16%

total Assets

$1,433.88M

total Debt

$445.29M

net Income

$9.30M

eps

$0.23

gross Margin

24.48%

cash Position

$33.64M

revenue Growth

+17.4%

Revenue Breakdown

Key Numbers

• $269.26M — Net Sales (Q3 2025) (Increased 17.4% from $229.36M in Q3 2024)
• $9.30M — Net Income (Q3 2025) (Increased 267.6% from $2.53M in Q3 2024)
• $785.69M — Net Sales (YTD 2025) (Increased 12.7% from $696.96M in YTD 2024)
• $38.44M — Net Income (YTD 2025) (Increased 106.6% from $18.61M in YTD 2024)
• $37.7M — Acquisition Cost (Acquisition of GMT aerospace business on February 17, 2025)
• $103.24M — Aerospace & Defense Sales (Q3 2025) (Increased 45.8% from $70.83M in Q3 2024)
• $8.03M — Asbestos-related costs (Q3 2025) (Increased from $5.51M in Q3 2024)
• $4.9M — Realignment Costs (YTD 2025) (Related to corporate office reorganization)
• 40,645,671 — Outstanding Common Shares (As of October 21, 2025)
• $33.64M — Cash and Cash Equivalents (Sept 30, 2025) (Increased from $23.07M at Dec 31, 2024)

Key Players & Entities

• TRIMAS CORP (company) — Registrant
• GMT Gummi-Metall-Technik GmbH (company) — Acquired aerospace business
• NASDAQ Stock Market LLC (regulator) — Exchange where TRS is registered
• Financial Accounting Standards Board (regulator) — Issued accounting standards updates
• $269.26 million (dollar_amount) — Net sales for three months ended September 30, 2025
• $9.30 million (dollar_amount) — Net income for three months ended September 30, 2025
• $37.7 million (dollar_amount) — Purchase price of GMT aerospace business
• $8.03 million (dollar_amount) — Asbestos-related costs for three months ended September 30, 2025
• $4.9 million (dollar_amount) — Realignment costs for nine months ended September 30, 2025
• Bloomberg (company) — Publisher of analysis

FAQ

Risk Factors

• Asbestos-Related Costs [medium — operational]: Asbestos-related costs increased to $8.03 million for Q3 2025 from $5.51 million in Q3 2024. This trend indicates a potential for escalating liabilities and operational burdens related to legacy issues.
• Realignment Costs [low — operational]: The company incurred $4.9 million in realignment costs year-to-date for corporate office reorganization, primarily for severance and consulting. While a one-time event, these costs impact short-term profitability.
• Input Cost Inflation and Supply Chain Disruptions [medium — market]: Management notes that input cost inflation, supply chain disruptions, and global shortages in commodities, logistics, and labor are key uncertainties. These factors can impact profitability and operational efficiency.
• Integration of Acquisitions [medium — financial]: The successful integration of the GMT Gummi-Metall-Technik GmbH aerospace business, acquired for $37.7 million, is crucial. Any integration challenges could affect the expected synergies and financial performance of the Aerospace & Defense segment.

Industry Context

TriMas operates in diverse markets including consumer products, aerospace & defense, and industrial. The aerospace sector is experiencing strong demand, as evidenced by the successful acquisition and performance of GMT Aerospace. The consumer products segment shows steady growth, while the industrial segment remains stable. The company faces competition across these segments, with a focus on innovative product design and engineering.

Regulatory Implications

The company must continue to manage asbestos-related liabilities, which are subject to evolving legal and regulatory frameworks. Additionally, ongoing compliance with accounting standards, particularly regarding acquisitions and revenue recognition, is critical.

What Investors Should Do

1. Monitor the integration of the GMT Aerospace acquisition.
2. Analyze the trend of asbestos-related costs.
3. Assess the impact of inflationary pressures and supply chain issues.

Key Dates

• 2025-02-17: Acquisition of GMT Gummi-Metall-Technik GmbH's aerospace business — Significantly boosted the Aerospace & Defense segment's sales and expanded the company's capabilities in this high-growth market.
• 2025-09-30: End of Q3 2025 — Reporting period for the strong financial results, including significant revenue and net income growth.
• 2025-10-21: Outstanding Common Shares as of — Provides the basis for EPS calculations and indicates the current equity structure.

Glossary

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its net identifiable assets and liabilities. (The acquisition of GMT Aerospace added $15.5 million in goodwill, reflecting the premium paid for the acquired business.)

Operating lease right-of-use assets

Assets recognized under lease accounting standards representing the right to use an asset for the lease term. (These assets, totaling $43.34 million, are part of the company's operational infrastructure.)

Accumulated other comprehensive income (loss)

A component of equity that includes unrealized gains and losses on certain investments, foreign currency translation adjustments, and pension plan adjustments. (A significant swing from a loss of $18.55 million at the end of 2024 to a gain of $1.51 million at September 30, 2025, indicates positive foreign currency translation effects.)

Realignment Costs

Expenses incurred due to restructuring or reorganizing business operations, often including severance and consulting fees. (The company incurred $4.9 million in realignment costs year-to-date, impacting SG&A expenses.)

Year-Over-Year Comparison

Compared to the prior year, TriMas has demonstrated significant top-line growth, with net sales up 17.4% for the quarter and 12.7% year-to-date, largely driven by the strategic acquisition in the Aerospace & Defense segment. Net income has more than doubled, reflecting improved operational leverage and the positive impact of the acquisition. Gross margins have expanded to 24.48% from approximately 22.5% in the prior year's comparable period. However, a notable increase in asbestos-related costs from $5.51 million to $8.03 million in the quarter presents a growing concern.

Key Financial Figures

• $0.01 — ange on which registered Common stock, $0.01 par value TRS The NASDAQ Stock Market L

Filing Documents

• trs-20250930.htm (10-Q) — 1623KB
• trs_09302025xexh311.htm (EX-31.1) — 8KB
• trs_09302025xexh312.htm (EX-31.2) — 8KB
• trs_09302025xexh321.htm (EX-32.1) — 4KB
• trs_09302025xexh322.htm (EX-32.2) — 4KB
• 0000842633-25-000125.txt ( ) — 10647KB
• trs-20250930.xsd (EX-101.SCH) — 87KB
• trs-20250930_cal.xml (EX-101.CAL) — 94KB
• trs-20250930_def.xml (EX-101.DEF) — 647KB
• trs-20250930_lab.xml (EX-101.LAB) — 1025KB
• trs-20250930_pre.xml (EX-101.PRE) — 832KB
• trs-20250930_htm.xml (XML) — 1509KB

Forward-Looking Statements

Forward-Looking Statements 2 Item 1. Consolidated Financial Statements 3 Consolidated Balance Sheet as of September 30, 2025 and December 31, 2024 3 Consolidated Statement of Income for the Three and Nine Months Ended September 30, 2025 and 2024 4 Consolidated Statement of Comprehensive Income for the Three and Nine Months Ended September 30, 2025 and 2024 5 Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 6 Consolidated Statement of Shareholders' Equity for the Nine Months Ended September 30, 2025 and 2024 7

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 28 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 45 Item 4.

Controls and Procedures

Controls and Procedures 45 Part II. Other Information Item 1.

Legal Proceedings

Legal Proceedings 46 Item 1A.

Risk Factors

Risk Factors 46 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 46 Item 3. Defaults Upon Senior Securities 46 Item 4. Mine Safety Disclosures 46 Item 5. Other Information 46 Item 6. Exhibits 47 Signature s 48 1 Table of Contents

Forward-Looking Statements

Forward-Looking Statements This report may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about our financial condition, results of operations and business. These forward-looking statements can be identified by the use of forward-looking words, such as "may," "could," "should," "estimate," "project," "forecast," "intend," "expect," "anticipate," "believe," "target," "plan" or other comparable words, or by discussions of strategy that may involve risks and uncertainties. These forward-looking statements are subject to numerous assumptions, risks and uncertainties which could materially affect our business, financial condition or future results including, but not limited to: general economic and currency conditions; competitive factors; market demand; our ability to realize our business strategies; government and regulatory actions, including, without limitation, the impact of current and future tariffs and reciprocal tariffs, quotas and surcharges, as well as climate change legislation and other environmental regulations; our ability to identify attractive acquisition candidates, successfully integrate acquired operations or realize the intended benefits of such acquisitions; pressures on our supply chain, including availability of raw materials and inflationary pressures on raw material and energy costs, and customers; the performance of our subcontractors and suppliers; risks and uncertainties associated with intangible assets, including goodwill or other intangible asset impairment charges; risks associated with a concentrated customer base; information technology and other cyber-related risks; risks related to our international operations, including, but not limited to, risks relating to tensions between the United States and China; changes to fiscal and tax policies; intellectual property factors; uncertainties associated with our ability to meet customer

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Consolidated Financial Statements

Item 1. Consolidated Financial Statements TriMas Corporation Consolidated Balance Sheet (Dollars in thousands) September 30, 2025 December 31, 2024 Assets (unaudited) Current assets: Cash and cash equivalents $ 33,640 $ 23,070 Receivables, net of reserves of $ 2.3 million and $ 3.2 million as of September 30, 2025 and December 31, 2024, respectively 192,060 164,820 Inventories 227,210 209,190 Prepaid expenses and other current assets 30,260 29,560 Total current assets 483,170 426,640 Property and equipment, net 340,540 318,650 Operating lease right-of-use assets 43,340 40,480 Goodwill 387,030 356,360 Other intangibles, net 158,330 161,080 Deferred income taxes 9,300 10,760 Other assets 12,170 10,210 Total assets $ 1,433,880 $ 1,324,180 Liabilities and Shareholders' Equity Current liabilities: Accounts payable $ 90,350 $ 91,050 Accrued liabilities 80,100 60,340 Lease liabilities, current portion 9,640 8,040 Total current liabilities 180,090 159,430 Long-term debt, net 407,070 398,120 Lease liabilities 38,220 36,680 Deferred income taxes 21,200 20,110 Other long-term liabilities 62,260 42,540 Total liabilities 708,840 656,880 Preferred stock, $ 0.01 par: Authorized 100,000,000 shares; Issued and outstanding: None — — Common stock, $ 0.01 par: Authorized 400,000,000 shares; Issued and outstanding: 40,642,475 shares at September 30, 2025 and 40,574,847 shares at December 31, 2024 410 410 Paid-in capital 668,050 663,770 Retained earnings 55,070 21,670 Accumulated other comprehensive income (loss) 1,510 ( 18,550 ) Total shareholders' equity 725,040 667,300 Total liabilities and shareholders' equity $ 1,433,880 $ 1,324,180 The accompanying notes are an integral part of these consolidated financial statements. 3 Table of Contents TriMas Corporation Consolidated Statement of Income (Unaudited—dollars in thousands, except for per share amounts) Three months ended September 30, Nine months ended September 30, 2025 2024

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) 1. Basis of Presentation TriMas Corporation ("TriMas" or the "Company"), and its consolidated subsidiaries, designs, engineers and manufactures innovative products under leading brand names for customers primarily in the consumer products, aerospace & defense, and industrial markets. The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries and, in the opinion of management, contain all adjustments, including adjustments of a normal and recurring nature, necessary for a fair presentation of financial position and results of operations. Certain prior year amounts have been reclassified to conform with the current year presentation; specifically asbestos-related costs, which was previously included within selling, general and administrative expenses, has now been separately presented on the consolidated statement of income. The preparation of financial statements requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities. Actual results may differ from such estimates and assumptions due to risks and uncertainties, including uncertainty and volatility in the current economic environment due to input cost inflation, supply chain disruptions, and shortages in global markets for commodities, logistics and labor. To the extent there are differences between these estimates and actual results, the Company's consolidated financial statements may be materially affected. Results of operations for interim periods are not necessarily indicative of results for the full year. The accompanying consolidated financial statements and notes thereto should be read in conjunction with the Company's 2024 Annual Report on Form 10-K. 2. New Accounting Pronouncements Recently Issued Accounting Pronouncements In July 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU"

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) (unaudited) 3. Revenue The following table presents the Company's disaggregated net sales by primary market served (dollars in thousands): Three months ended September 30, Nine months ended September 30, Customer Markets 2025 2024 2025 2024 Consumer Products $ 110,480 $ 105,390 $ 330,980 $ 315,950 Aerospace & Defense 103,240 70,830 295,460 215,890 Industrial 55,540 53,140 159,250 165,120 Total net sales $ 269,260 $ 229,360 $ 785,690 $ 696,960 The Company's Packaging segment earns revenues from the consumer products (comprised of the beauty and personal care, food and beverage, home care, pharmaceutical, nutraceutical and medical submarkets) and industrial markets. The Aerospace segment earns revenues from the aerospace & defense market (comprised of commercial, regional and business jet, and military submarkets). The Specialty Products segment earns revenues from a variety of submarkets within the industrial market. As of September 30, 2025, the Company's total deferred revenue and related contract assets were $ 7.5 million and $ 4.4 million, respectively, and were included in accrued liabilities and prepaid expenses and other current assets, respectively, in the accompanying consolidated balance sheet. As of December 31, 2024, the Company's total deferred revenue and related contract assets were immaterial. 4. Realignment Actions 2025 Realignment Actions During the three and nine months ended September 30, 2025, the Company recorded $ 0.4 million and $ 4.9 million, respectively, of realignment costs related to actions to reorganize its corporate office, primarily for severance and consulting costs, including $ 1.5 million of non-cash compensation expense during the nine months ended September 30, 2025. These charges were included in selling, general and administrative expenses in the accompanying consolidated statement of income. 2024 Realignment Actions During the three and nine months ended

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) (unaudited) 6. Goodwill and Other Intangible Assets Goodwill Changes in the carrying amount of goodwill for the nine months ended September 30, 2025 are summarized as follows (dollars in thousands): Packaging Aerospace Specialty Products Total Balance, December 31, 2024 $ 280,500 $ 69,300 $ 6,560 $ 356,360 Goodwill from acquisitions — 15,490 — 15,490 Foreign currency translation and other 13,130 2,050 — 15,180 Balance, September 30, 2025 $ 293,630 $ 86,840 $ 6,560 $ 387,030 Other Intangible Assets The Company amortizes its other intangible assets over periods ranging from one to 30 years. The gross carrying amounts and accumulated amortization of the Company's other intangibles are summarized below (dollars in thousands): As of September 30, 2025 As of December 31, 2024 Intangible Category by Useful Life Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Finite-lived intangible assets: Customer relationships, 5 – 12 years $ 147,350 $ ( 102,920 ) $ 138,840 $ ( 95,360 ) Customer relationships, 15 – 25 years 129,460 ( 91,370 ) 129,230 ( 86,690 ) Total customer relationships 276,810 ( 194,290 ) 268,070 ( 182,050 ) Technology and other, 1 – 15 years 56,210 ( 45,000 ) 56,790 ( 44,590 ) Technology and other, 17 – 30 years 43,300 ( 41,350 ) 43,300 ( 41,080 ) Total technology and other 99,510 ( 86,350 ) 100,090 ( 85,670 ) Indefinite-lived intangible assets: Trademark/Trade names 62,650 — 60,640 — Total other intangible assets $ 438,970 $ ( 280,640 ) $ 428,800 $ ( 267,720 ) Amortization expense related to intangible assets as included in the accompanying consolidated statement of income is summarized as follows (dollars in thousands): Three months ended September 30, Nine months ended September 30, 2025 2024 2025 2024 Technology and other, included in cost of sales $ 810 $ 810 $ 2,400 $ 2,470 Customer relationships, included in selling, gene

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) (unaudited) 7. Inventories Inventories consist of the following components (dollars in thousands): September 30, 2025 December 31, 2024 Finished goods $ 95,630 $ 86,430 Work in process 61,620 62,380 Raw materials 69,960 60,380 Total inventories $ 227,210 $ 209,190 8. Property and Equipment, Net Property and equipment consists of the following components (dollars in thousands): September 30, 2025 December 31, 2024 Land and land improvements $ 30,540 $ 30,810 Buildings 92,820 93,780 Machinery and equipment 571,150 524,390 694,510 648,980 Less: Accumulated depreciation 353,970 330,330 Property and equipment, net $ 340,540 $ 318,650 Depreciation expense as included in the accompanying consolidated statement of income is as follows (dollars in thousands): Three months ended September 30, Nine months ended September 30, 2025 2024 2025 2024 Depreciation expense, included in cost of sales $ 9,880 $ 9,660 $ 29,040 $ 29,150 Depreciation expense, included in selling, general and administrative expenses 240 280 730 790 Total depreciation expense $ 10,120 $ 9,940 $ 29,770 $ 29,940 9. Long-term Debt The Company's long-term debt consists of the following (dollars in thousands): September 30, 2025 December 31, 2024 4.125% Senior Notes due April 2029 $ 400,000 $ 400,000 Credit Agreement 10,890 1,500 Debt issuance costs ( 3,820 ) ( 3,380 ) Long-term debt, net $ 407,070 $ 398,120 Senior Notes In March 2021, the Company issued $ 400.0 million aggregate principal amount of 4.125 % senior notes due April 15, 2029 ("Senior Notes") at par value in a private placement under Rule 144A of the Securities Act of 1933, as amended ("Securities Act"). The Senior Notes accrue interest at a rate of 4.125 % per annum, payable semi-annually in arrears on April 15 and October 15. The payment of principal and interest is jointly and severally guaranteed, on a senior unse

View Full Filing

View this 10-Q filing on SEC EDGAR